SweetValueLab
Write for us

Marvell Technology, Inc. — Wall Street Analyst Estimates & Price Targets

MRVL
NASDAQTechnologySemiconductorsCIK 0001835632marvell.comAbout MRVL
Last close · Oct 16, 2026227.83−13.41 (−5.56%)
Market cap$199.5B

20 firms' latest targets, last 90 days: median $357.50 ($225.00–$450.00), 57% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$100$200$300$400NovJan 2026MarMayJulSep2025-11-20 · Raymond James: $1212025-11-24 · UBS: $1102025-11-24 · HSBC: $85.02025-12-01 · Morgan Stanley: $86.02025-12-03 · Jefferies: $1202025-12-03 · Craig-Hallum: $1412025-12-03 · Morgan Stanley: $1122025-12-03 · UBS: $1002025-12-03 · Roth Capital: $1352025-12-03 · Evercore ISI: $1562025-12-03 · Cantor Fitzgerald: $1102025-12-03 · Susquehanna: $1202025-12-03 · Piper Sandler: $1102025-12-03 · Oppenheimer: $1502025-12-03 · Susquehanna: $1302025-12-03 · KeyBanc: $1302025-12-03 · Goldman Sachs: $90.02025-12-03 · Stifel: $1142025-12-03 · Piper Sandler: $1352025-12-03 · Wells Fargo: $1352025-12-03 · Barclays: $1052025-12-03 · Deutsche Bank: $1252025-12-16 · Cantor Fitzgerald: $1002026-01-05 · Melius Research: $1352026-01-14 · RBC Capital: $1052026-02-03 · UBS: $1152026-02-10 · Deutsche Bank: $1202026-02-23 · UBS: $1202026-03-04 · Evercore ISI: $1332026-03-06 · Craig-Hallum: $1642026-03-06 · Rosenblatt Securities: $1402026-03-06 · Stifel: $1202026-04-09 · Cantor Fitzgerald: $1202026-04-09 · Barclays: $1502026-04-15 · Oppenheimer: $1702026-04-16 · Stifel: $1402026-04-21 · RBC Capital: $1702026-05-04 · UBS: $1952026-05-13 · Goldman Sachs: $1252026-05-14 · RBC Capital: $2002026-05-18 · Melius Research: $2202026-05-19 · Evercore ISI: $1552026-05-20 · Oppenheimer: $2002026-05-20 · Wells Fargo: $1952026-05-22 · Stifel: $2102026-05-26 · Morgan Stanley: $1722026-05-26 · HSBC: $3002026-05-26 · Susquehanna: $2302026-05-26 · Cantor Fitzgerald: $1902026-05-26 · Compass Point: $1902026-05-27 · Roth Capital: $2752026-05-28 · Oppenheimer: $2502026-05-28 · TD Cowen: $2002026-05-28 · Cantor Fitzgerald: $2202026-05-28 · KeyBanc: $2602026-05-28 · Stifel: $2302026-05-28 · Needham: $2702026-05-28 · Morgan Stanley: $1952026-05-28 · Rosenblatt Securities: $2402026-05-28 · UBS: $2302026-05-28 · Wells Fargo: $2402026-05-28 · Barclays: $2752026-05-28 · Jefferies: $2352026-05-28 · Raymond James: $2352026-05-28 · Deutsche Bank: $2402026-05-28 · Goldman Sachs: $1802026-06-02 · Stifel: $3212026-06-12 · B. Riley: $3452026-06-18 · KeyBanc: $3852026-06-24 · Stifel: $3502026-06-29 · UBS: $3402026-06-29 · Cantor Fitzgerald: $3002026-07-14 · KeyBanc: $4002026-08-12 · Goldman Sachs: $1952026-08-17 · UBS: $3002026-08-18 · D.A. Davidson: $2252026-08-20 · BMO Capital: $2502026-08-20 · Roth Capital: $3502026-08-20 · Jefferies: $3252026-08-20 · UBS: $3102026-08-21 · Oppenheimer: $3002026-08-24 · UBS: $2752026-08-24 · Morgan Stanley: $2242026-08-24 · Wells Fargo: $3102026-08-25 · Susquehanna: $2652026-08-28 · Craig-Hallum: $3002026-08-28 · Oppenheimer: $3252026-08-28 · Needham: $3002026-08-28 · Goldman Sachs: $2202026-08-28 · Wolfe Research: $2802026-08-28 · Morgan Stanley: $2462026-09-09 · Piper Sandler: $2702026-09-21 · Morgan Stanley: $2682026-09-22 · Seaport Global: $2702026-09-28 · RBC Capital: $3602026-09-28 · Cantor Fitzgerald: $3302026-10-06 · Jefferies: $4502026-10-06 · Evercore ISI: $4332026-10-06 · Raymond James: $2952026-10-07 · Wolfe Research: $3752026-10-07 · Craig-Hallum: $3802026-10-07 · RBC Capital: $4252026-10-07 · Oppenheimer: $4252026-10-07 · BMO Capital: $3252026-10-07 · Goldman Sachs: $2702026-10-07 · Susquehanna: $3402026-10-07 · Cantor Fitzgerald: $3502026-10-07 · Stifel: $3702026-10-07 · UBS: $3502026-10-07 · Morgan Stanley: $3002026-10-07 · Needham: $4002026-10-07 · Piper Sandler: $4002026-10-07 · Wells Fargo: $365
$100$200$300$400NovFebMayAug

Each firm's latest target

last 90 days · 20 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-07Wolfe Research$375.00$280.00▲ 34%+34%+65%
2026-10-07Craig-Hallum$380.00$300.00▲ 27%+35%+67%
2026-10-07RBC Capital$425.00$360.00▲ 18%+52%+87%
2026-10-07Oppenheimer$425.00$325.00▲ 31%+52%+87%
2026-10-07BMO Capital$325.00$250.00▲ 30%+16%+43%
2026-10-07Goldman Sachs$270.00$220.00▲ 23%-6%+19%
2026-10-07Susquehanna$340.00$265.00▲ 28%+18%+49%
2026-10-07Cantor Fitzgerald$350.00$330.00▲ 6%+22%+54%
2026-10-07Stifel$370.00$350.00▲ 6%+29%+62%
2026-10-07UBS$350.00$275.00▲ 27%+22%+54%
2026-10-07Morgan Stanley$300.00$268.00▲ 12%+5%+32%
2026-10-07Needham$400.00$300.00▲ 33%+39%+76%
2026-10-07Piper Sandler$400.00$270.00▲ 48%+39%+76%
2026-10-07Wells Fargo$365.00$310.00▲ 18%+27%+60%
2026-10-06Jefferies$450.00$325.00▲ 38%+57%+98%
2026-10-06Evercore ISI$433.00$155.00▲ 179%+51%+90%
2026-10-06Raymond James$295.00$235.00▲ 26%+3%+29%
2026-09-22Seaport Global$270.00——+3%+19%
2026-08-20Roth Capital$350.00$275.00▲ 27%+42%+54%
2026-08-18D.A. Davidson$225.00——+6%-1%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2024reported$5.5B-7%-$1.08—est. $5.5B+0%est. $1.5119
2025reported$5.8B+5%-$1.02—est. $5.7B+0%est. $1.5624
2026reported$8.2B+42%$3.07—est. $8.2B+0%est. $2.8426
2027$12.1B+47%$4.21+48%$12.0B–$12.2B$4.17–$4.2831
2028$19.5B+62%$7.28+73%$17.7B–$20.2B$6.20–$7.7628
2029$31.4B+61%$12.40+70%$23.0B–$38.1B$5.05–$16.1635
2030$48.1B+53%$18.47+49%$42.9B–$53.0B$15.85–$20.8825
2031$75.0B+56%$28.26+53%$66.8B–$82.5B$24.25–$31.9516
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.